Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Endosera
- Development stage
- Unknown
- Lead developer
- Seragen Biotherapeutics
- Modality
- Peptides
- Administration
- Vaginal
01
Overview
Endosera is an autologous, cell-free, standardized platelet-derived growth factor (PDGF) concentrate developed by Seragen Biotherapeutics. It is designed as a co-adjuvant therapy for women with recurrent implantation failure (RIF) and refractory thin endometrium undergoing assisted reproductive techniques (ART). The preparation is optimized for the proliferation, secretion, and implantation phases of the endometrium, containing 6–9 times higher concentrations of growth factors compared to peripheral blood. By promoting angiogenesis, immunomodulation, and tissue repair, Endosera aims to restore endometrial receptivity and improve clinical pregnancy and live birth rates in patients who have failed conventional treatments.
- Brand names
- Endosera
- Other names
- Autologous platelet-derived growth factor therapyAutologous Platelet Derived Growth Factors
02
Targets
PDGFRB (Platelet-derived growth factor receptor beta)IGF-1R (Insulin-like growth factor 1 receptor)VEGFR-1 (Vascular endothelial growth factor receptor 1)PDGFRA (Platelet-derived growth factor receptor alpha)TGFBR (TGF-beta receptor)
Beyond the preview
Go deeper on Endosera.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Endosera.